Home Data Calendar Blog

RIGL

Tables

		2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2017-12-31	2017-09-30	2017-06-30	2017-03-31
Common Stock Value		0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.15	0.12	0.12	0.12
Weighted Average Number Of Diluted Shares Outstanding		175.20	NA	174.36	173.75	173.57	NA	172.84	172.15	171.77	NA	170.89	170.19	176.07	169.04	168.93	168.57	168.57	167.75	167.61	167.19	167.17	167.62	166.46	161.58	144.25	124.63	122.50	113.60
Weighted Average Number Of Shares Outstanding Basic		175.20	NA	174.36	173.75	173.57	NA	172.84	172.15	171.77	NA	170.89	170.19	169.80	169.04	168.93	168.57	168.47	167.62	167.61	167.19	167.17	166.68	166.46	161.58	144.25	124.63	122.50	113.60
Earnings Per Share Basic		-0.05	0.01	-0.03	-0.04	-0.08	0.01	-0.11	-0.08	-0.16	-0.14	-0.12	-0.08	0.23	-0.12	-0.08	-0.10	0.13	NA	NA	NA	-0.11	NA	NA	NA	NA	NA	NA	NA
Earnings Per Share Diluted		-0.05	0.01	-0.03	-0.04	-0.08	0.01	-0.11	-0.08	-0.16	-0.14	-0.12	-0.08	0.22	-0.12	-0.08	-0.10	0.13	NA	NA	NA	-0.11	NA	NA	NA	NA	NA	NA	NA

		2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2017-12-31	2017-09-30	2017-06-30	2017-03-31
Revenue From Contract With Customer Excluding Assessed Tax		29.53	35.79	28.13	26.89	26.07	51.28	22.41	29.82	16.73	20.41	21.54	26.27	81.02	18.45	18.39	16.02	55.76	15.40	20.86	10.41	12.62	37.86	4.87	1.79	0.00	0.90	0.00	3.58
Revenues		29.53	35.79	28.13	26.89	26.07	51.28	22.41	29.82	16.73	20.41	21.54	26.27	81.02	18.45	18.39	16.02	55.76	15.40	20.86	10.41	12.62	37.86	4.87	1.79	0.00	0.90	0.00	3.58
Cost Of Goods And Services Sold		2.02	3.79	1.27	1.07	0.98	0.34	0.25	1.04	0.12	0.49	0.15	0.13	0.32	0.32	0.14	0.28	0.15	0.18	0.31	0.31	0.11	0.19	0.07	0.03	NA	NA	NA	NA
Costs And Expenses		36.50	33.83	32.60	32.15	38.80	49.20	40.81	42.78	43.00	41.83	41.33	39.31	39.26	37.28	32.17	33.41	34.73	32.74	32.89	31.75	31.00	35.33	29.23	27.90	26.21	18.75	19.34	19.79
Research And Development Expense Excluding Acquired In Process Cost		6.03	3.19	6.47	4.77	10.09	15.37	14.67	14.77	15.47	13.30	18.30	16.81	16.83	15.14	14.60	14.21	16.15	14.25	14.46	13.23	10.95	13.77	11.10	10.80	11.56	10.81	11.52	12.38
Selling General And Administrative Expense		28.45	26.85	24.86	26.31	27.73	32.17	25.90	26.98	27.40	24.52	22.88	22.38	22.12	21.82	17.43	18.92	18.43	18.31	18.12	18.21	19.95	21.37	18.07	17.07	NA	NA	NA	NA
Operating Income Loss		-6.97	1.97	-4.46	-5.27	-12.72	2.08	-18.40	-12.96	-26.26	-21.42	-19.79	-13.05	41.76	-18.83	-13.78	-17.39	21.03	-17.34	-12.04	-21.34	-18.38	2.53	-24.37	-26.11	-26.21	-17.86	-19.34	-16.20
Interest Expense		1.87	1.91	1.90	1.86	1.20	1.11	0.83	0.57	1.21	1.30	1.32	1.76	0.48	0.43	0.43	0.35	0.14	0.33	0.01	NA	NA	NA	NA	NA	NA	NA	NA	NA
Interest Paid Net		1.68	1.68	1.68	1.47	1.01	0.95	0.60	0.56	0.39	0.41	0.37	0.36	0.36	0.37	0.37	0.24	0.20	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Allocated Share Based Compensation Expense		5.13	1.93	1.94	2.17	2.76	4.08	2.71	2.39	3.21	2.34	2.20	2.31	2.64	1.63	1.88	1.76	2.02	1.41	2.10	2.65	2.95	2.06	3.00	1.11	3.06	0.87	1.10	0.95
Profit Loss		-8.25	0.74	-5.69	-6.60	-13.54	1.40	-19.04	-13.49	-27.45	-22.64	-20.95	-13.82	39.50	-19.24	-14.17	-17.58	21.24	-17.20	-11.49	-20.61	-17.60	3.23	-23.77	-25.56	-25.87	-17.66	-19.15	-15.31
Net Income Loss		-8.25	0.74	-5.69	-6.60	-13.54	1.40	-19.04	-13.49	-27.45	-22.64	-20.95	-13.82	39.50	-19.24	-14.17	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Comprehensive Income Net Of Tax		-8.26	0.76	-5.68	-6.60	-13.41	1.53	-18.89	-13.51	-27.76	-22.75	-20.95	-13.81	39.50	-19.24	-14.22	-17.61	21.30	-17.21	-11.50	-20.57	-17.56	3.23	-23.74	-25.52	-25.95	-17.65	-19.14	-15.32
Net Income Loss Available To Common Stockholders Basic		-8.25	0.74	-5.69	-6.60	-13.54	1.40	-19.04	-13.49	-27.45	-22.64	-20.95	-13.82	39.50	-19.24	-14.17	-17.58	21.24	-17.20	-11.49	-20.61	-17.60	3.23	-23.77	-25.56	-25.87	-17.66	-19.15	-15.31

		2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2017-12-31	2017-09-30	2017-06-30	2017-03-31
Assets		126.52	117.22	115.32	117.09	123.61	134.28	115.61	128.00	149.07	167.33	186.52	201.60	215.99	110.38	123.06	138.03	143.36	147.57	156.06	156.16	172.78	139.11	123.17	141.22	119.11	71.25	85.48	101.33
Liabilities		158.19	145.87	147.16	145.21	147.87	147.90	NA	NA	NA	136.95	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Liabilities And Stockholders Equity		126.52	117.22	115.32	117.09	123.61	134.28	115.61	128.00	149.07	167.33	186.52	201.60	215.99	110.38	123.06	138.03	143.36	147.57	156.06	156.16	172.78	139.11	123.17	141.22	119.11	71.25	85.48	101.33
Stockholders Equity		-31.67	-28.64	-31.83	-28.11	-24.26	-13.62	-19.83	-3.68	6.80	30.37	49.67	68.11	78.30	34.03	50.95	63.21	78.50	53.81	68.91	78.29	95.31	109.88	103.47	123.57	100.65	56.17	69.61	84.08

		2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2017-12-31	2017-09-30	2017-06-30	2017-03-31
Assets Current		92.49	99.27	95.02	100.92	106.97	115.90	110.44	120.52	138.94	154.47	171.10	184.20	196.76	88.98	99.85	113.09	116.33	119.00	126.00	124.50	139.32	136.99	121.04	139.06	117.43	69.56	83.79	99.52
Cash And Cash Equivalents At Carrying Value		25.57	32.79	45.41	48.81	40.28	24.46	29.87	27.20	24.68	18.89	30.40	84.82	20.05	30.37	36.57	36.47	45.23	22.52	39.09	44.23	74.70	76.32	61.49	65.08	38.29	25.88	32.59	40.14
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents		25.57	32.79	45.41	48.81	40.28	24.46	29.87	27.20	24.68	18.89	30.40	84.82	20.05	30.37	NA	NA	NA	22.52	NA	NA	NA	76.32	NA	NA	NA	NA	NA	NA
Short Term Investments		23.98	24.15	16.94	15.54	18.38	33.75	51.78	61.97	82.84	106.08	112.74	68.56	19.30	26.95	36.24	56.03	50.70	75.56	68.39	68.15	53.23	52.22	54.15	69.91	77.46	42.20	49.71	58.00
Accounts Receivable Net Current		27.51	30.55	23.55	20.82	29.37	40.32	15.53	17.20	15.24	15.47	14.99	17.37	142.19	15.97	14.63	11.73	9.66	10.11	11.55	6.93	5.61	4.08	NA	NA	0.00	NA	NA	NA
Inventory Net		6.58	5.52	6.11	10.78	11.08	9.12	7.12	6.22	6.76	6.62	7.04	6.83	6.95	1.64	2.05	1.68	1.62	1.35	1.18	1.22	1.13	0.89	NA	NA	NA	NA	NA	NA
Inventory Finished Goods		1.27	1.51	1.23	1.86	2.12	1.90	1.32	1.09	1.17	1.31	1.41	1.35	0.96	0.45	1.01	1.17	1.24	0.54	0.37	0.16	0.30	0.36	NA	NA	NA	NA	NA	NA
Prepaid Expense And Other Assets Current		8.85	6.26	3.02	4.97	7.87	8.26	6.16	7.94	9.41	7.41	5.93	6.61	8.27	14.04	10.36	7.18	9.12	9.46	5.79	3.97	4.65	3.48	1.56	1.55	1.68	1.49	1.49	1.38

		2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2017-12-31	2017-09-30	2017-06-30	2017-03-31
Property Plant And Equipment Gross		NA	1.87	NA	NA	NA	11.66	NA	NA	NA	16.73	NA	NA	NA	16.35	NA	NA	NA	15.20	NA	NA	NA	14.24	NA	NA	13.15	NA	NA	NA
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment		NA	1.70	NA	NA	NA	10.81	NA	NA	NA	14.55	NA	NA	NA	13.68	NA	NA	NA	13.04	NA	NA	NA	12.85	NA	NA	12.28	NA	NA	NA
Amortization Of Intangible Assets		0.40	NA	NA	NA	0.30	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Property Plant And Equipment Net		0.14	0.17	0.19	0.21	0.29	0.86	1.69	1.83	2.14	2.18	2.65	2.67	2.50	2.68	2.52	2.38	2.60	2.16	1.72	1.53	1.60	1.39	1.48	1.48	0.88	0.92	0.98	1.07
Finite Lived Intangible Assets Net		28.86	13.88	NA	NA	NA	14.95	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Intangible Assets Net Including Goodwill		28.86	13.88	14.15	14.41	14.68	14.95	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Other Assets Noncurrent		4.32	3.06	4.96	0.54	0.54	0.64	0.48	0.40	0.46	0.97	0.94	0.84	0.82	0.82	0.82	0.65	0.66	0.70	0.69	0.71	0.73	0.73	0.65	0.68	0.80	0.77	0.70	0.73
Available For Sale Debt Securities Amortized Cost Basis		33.95	38.99	38.07	34.48	38.40	47.94	70.14	67.90	91.50	111.98	114.73	94.55	26.40	35.86	53.69	67.98	57.32	87.23	78.89	100.18	NA	116.83	NA	NA	NA	NA	NA	NA

		2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2017-12-31	2017-09-30	2017-06-30	2017-03-31
Liabilities Current		73.20	53.27	48.27	44.02	45.52	65.21	47.27	54.95	59.23	63.55	59.28	59.54	52.02	40.84	34.19	34.76	31.17	58.21	31.01	28.38	26.14	27.73	19.70	17.36	18.34	15.01	15.87	17.25
Accounts Payable Current		9.28	7.14	8.00	5.24	6.29	22.51	2.72	2.15	4.61	3.79	3.14	1.69	5.09	3.71	2.28	3.41	2.21	4.15	2.66	3.78	1.18	6.39	2.64	3.34	2.64	2.19	2.07	1.18
Other Accrued Liabilities Current		5.43	5.33	5.03	5.01	5.10	6.49	17.60	16.89	16.50	12.69	13.49	12.36	11.07	11.01	9.04	7.64	6.93	6.72	6.81	4.93	NA	3.60	3.75	3.09	3.33	1.52	1.00	1.47
Other Liabilities Current		1.00	3.64	4.83	5.70	5.62	5.00	5.91	11.82	11.59	13.51	10.98	16.23	5.47	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Contract With Customer Liability Current		1.35	1.35	1.35	1.35	1.37	1.37	1.37	1.54	2.10	2.60	3.16	5.81	9.50	3.02	3.07	3.21	2.05	25.29	1.59	1.36	1.53	1.03	NA	NA	NA	NA	NA	NA

		2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2017-12-31	2017-09-30	2017-06-30	2017-03-31
Long Term Debt		60.00	60.00	60.00	60.00	60.00	40.00	40.00	30.00	30.00	20.00	20.00	20.00	20.00	20.00	20.00	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Other Liabilities Noncurrent		39.98	39.94	38.76	40.98	42.06	42.26	48.71	46.89	53.20	52.73	54.37	48.23	57.53	5.04	5.00	5.00	5.00	5.10	NA	NA	NA	NA	NA	0.04	0.04	0.08	NA	NA
Operating Lease Liability Noncurrent		0.10	0.28	0.47	0.63	0.80	0.97	NA	NA	NA	0.76	3.31	5.85	8.30	10.65	12.93	15.25	17.30	19.23	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA

		2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2017-12-31	2017-09-30	2017-06-30	2017-03-31
Stockholders Equity		-31.67	-28.64	-31.83	-28.11	-24.26	-13.62	-19.83	-3.68	6.80	30.37	49.67	68.11	78.30	34.03	50.95	63.21	78.50	53.81	68.91	78.29	95.31	109.88	103.47	123.57	100.65	56.17	69.61	84.08
Common Stock Value		0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.15	0.12	0.12	0.12
Additional Paid In Capital Common Stock		1383.96	1378.72	1376.29	1374.33	1371.59	1368.82	1364.14	1361.41	1358.37	1354.19	1350.74	1348.22	1344.60	1339.83	1337.52	1335.56	1333.24	1329.85	1327.73	1325.62	1322.07	1319.07	1315.89	1312.25	1239.43	1169.03	1164.82	1160.16
Retained Earnings Accumulated Deficit		-1415.80	-1407.55	-1408.29	-1402.60	-1395.99	-1382.46	-1383.86	-1364.82	-1351.33	-1323.89	-1301.24	-1280.29	-1266.47	-1305.97	-1286.73	-1272.56	-1254.98	-1276.23	-1259.03	-1247.54	-1226.93	-1209.33	-1212.56	-1188.80	-1138.85	-1112.98	-1095.32	-1076.18
Accumulated Other Comprehensive Income Loss Net Of Tax		-0.01	0.01	-0.01	-0.03	-0.03	-0.15	-0.29	-0.44	-0.42	-0.10	0.01	0.01	-0.00	-0.00	0.00	0.05	0.08	0.02	0.04	0.04	0.01	-0.02	-0.03	-0.05	-0.08	-0.01	-0.02	-0.03
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value		5.14	NA	1.96	2.19	2.77	NA	2.73	2.44	3.24	NA	2.24	2.31	2.67	NA	1.91	1.78	2.05	NA	2.11	2.69	2.99	NA	3.01	1.13	NA	NA	NA	NA

		2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2017-12-31	2017-09-30	2017-06-30	2017-03-31
Net Cash Provided By Used In Operating Activities		-5.01	-6.24	-1.36	5.93	-4.07	-21.91	-13.30	-12.91	-25.64	-19.09	-10.30	55.22	-19.95	-15.57	-19.48	-14.04	-3.09	-9.65	-14.64	-16.65	-0.57	11.64	-20.08	-26.99	-19.71	-17.61	-19.47	-20.76
Net Cash Provided By Used In Investing Activities		0.31	-6.87	-1.17	2.97	0.78	18.60	10.46	21.09	22.63	6.49	-44.40	-49.66	7.53	8.71	19.53	-5.23	24.46	-7.62	-0.29	-14.67	-1.07	2.09	15.86	-16.20	-35.24	7.56	8.36	-0.15
Net Cash Provided By Used In Financing Activities		-2.51	0.49	-0.87	-0.37	19.12	-2.10	5.51	-5.66	8.80	1.08	0.27	59.22	2.10	0.67	0.05	10.52	1.34	0.69	9.80	0.86	0.02	1.10	0.64	68.15	67.37	3.34	3.56	43.42

		2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2017-12-31	2017-09-30	2017-06-30	2017-03-31
Net Cash Provided By Used In Operating Activities		-5.01	-6.24	-1.36	5.93	-4.07	-21.91	-13.30	-12.91	-25.64	-19.09	-10.30	55.22	-19.95	-15.57	-19.48	-14.04	-3.09	-9.65	-14.64	-16.65	-0.57	11.64	-20.08	-26.99	-19.71	-17.61	-19.47	-20.76
Net Income Loss		-8.25	0.74	-5.69	-6.60	-13.54	1.40	-19.04	-13.49	-27.45	-22.64	-20.95	-13.82	39.50	-19.24	-14.17	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Profit Loss		-8.25	0.74	-5.69	-6.60	-13.54	1.40	-19.04	-13.49	-27.45	-22.64	-20.95	-13.82	39.50	-19.24	-14.17	-17.58	21.24	-17.20	-11.49	-20.61	-17.60	3.23	-23.77	-25.56	-25.87	-17.66	-19.15	-15.31
Depreciation Depletion And Amortization		0.40	0.29	0.29	0.30	0.36	0.28	0.24	0.24	0.24	0.40	0.26	0.26	0.24	0.21	0.17	0.16	0.17	0.18	0.17	0.17	0.16	0.16	0.16	0.16	0.11	0.11	0.11	0.13
Increase Decrease In Accounts Receivable		-3.04	7.00	2.73	-8.55	-10.95	24.80	-1.67	1.96	-0.23	0.48	-2.38	-124.82	126.22	1.34	2.90	2.07	-0.45	-1.44	4.62	1.32	1.54	0.80	1.65	NA	NA	NA	NA	NA
Increase Decrease In Inventories		2.31	-2.53	-0.28	-0.31	1.95	1.98	0.88	-0.59	0.11	-0.45	0.17	-0.11	5.27	-0.11	-0.04	0.04	0.24	0.17	-0.05	0.04	0.20	0.34	0.02	NA	NA	NA	NA	NA
Increase Decrease In Accounts Payable		2.13	-0.86	2.76	-1.05	-1.21	4.79	0.59	-2.44	0.85	0.70	1.37	-3.42	1.39	1.54	-1.13	1.21	-1.95	1.49	-1.12	2.60	-5.21	3.75	-0.70	1.20	0.44	0.12	0.88	-4.38
Share Based Compensation		5.13	1.93	1.94	2.17	2.76	4.08	2.71	2.39	3.21	2.34	2.20	2.31	2.64	1.63	1.88	1.76	2.02	1.41	2.10	2.65	2.95	2.06	3.00	1.11	3.06	0.87	1.10	0.95

		2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2017-12-31	2017-09-30	2017-06-30	2017-03-31
Net Cash Provided By Used In Investing Activities		0.31	-6.87	-1.17	2.97	0.78	18.60	10.46	21.09	22.63	6.49	-44.40	-49.66	7.53	8.71	19.53	-5.23	24.46	-7.62	-0.29	-14.67	-1.07	2.09	15.86	-16.20	-35.24	7.56	8.36	-0.15

		2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2017-12-31	2017-09-30	2017-06-30	2017-03-31
Net Cash Provided By Used In Financing Activities		-2.51	0.49	-0.87	-0.37	19.12	-2.10	5.51	-5.66	8.80	1.08	0.27	59.22	2.10	0.67	0.05	10.52	1.34	0.69	9.80	0.86	0.02	1.10	0.64	68.15	67.37	3.34	3.56	43.42

		2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2017-12-31	2017-09-30	2017-06-30	2017-03-31
Revenues		29.53	35.79	28.13	26.89	26.07	51.28	22.41	29.82	16.73	20.41	21.54	26.27	81.02	18.45	18.39	16.02	55.76	15.40	20.86	10.41	12.62	37.86	4.87	1.79	0.00	0.90	0.00	3.58
Contract Revenues From Collaborations		3.53	6.15	1.00	2.00	2.33	26.50	0.72	11.27	0.54	1.84	4.53	3.71	65.64	0.70	2.10	1.05	43.08	1.57	9.14	0.23	4.57	NA	NA	NA	NA	NA	NA	NA
Development Milestones		NA	0.00	0.07	NA	NA	20.00	0.00	5.00	NA	0.00	1.88	NA	NA	0.00	2.10	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Discounts And Allowances		-12.42	-12.28	-11.46	-9.57	-9.45	-9.72	-7.79	-7.88	-6.42	-4.92	-4.53	-4.98	-3.73	-4.67	-4.03	-3.38	-2.69	-2.51	-2.63	-2.31	-1.86	-1.24	-1.27	-0.50	NA	NA	NA	NA
Gross Product		38.43	41.82	38.59	33.46	33.20	32.50	26.98	26.43	22.62	22.49	20.55	22.04	16.11	22.43	20.32	18.35	15.37	16.34	14.35	12.48	9.92	8.53	6.13	2.29	NA	NA	NA	NA
Royalty Delivery Of Drug Supplies And Others		3.53	6.15	0.93	2.00	2.33	1.11	0.72	3.93	0.33	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Government Contract		NA	0.10	0.00	1.00	NA	2.00	2.50	NA	NA	1.00	1.00	5.50	3.00	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Product		26.00	29.54	27.13	23.88	23.75	22.78	19.19	18.55	16.20	17.57	16.01	17.05	12.38	17.75	16.29	14.97	12.68	13.83	11.72	10.17	8.05	7.29	4.87	1.79	NA	NA	NA	NA
Revenue From Contract With Customer Excluding Assessed Tax		29.53	35.79	28.13	26.89	26.07	51.28	22.41	29.82	16.73	20.41	21.54	26.27	81.02	18.45	18.39	16.02	55.76	15.40	20.86	10.41	12.62	37.86	4.87	1.79	0.00	0.90	0.00	3.58
Contract Revenues From Collaborations		3.53	6.15	1.00	2.00	2.33	26.50	0.72	11.27	0.54	1.84	4.53	3.71	65.64	0.70	2.10	1.05	43.08	1.57	9.14	0.23	4.57	NA	NA	NA	NA	NA	NA	NA
Development Milestones		NA	0.00	0.07	NA	NA	20.00	0.00	5.00	NA	0.00	1.88	NA	NA	0.00	2.10	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Discounts And Allowances		-12.42	-12.28	-11.46	-9.57	-9.45	-9.72	-7.79	-7.88	-6.42	-4.92	-4.53	-4.98	-3.73	-4.67	-4.03	-3.38	-2.69	-2.51	-2.63	-2.31	-1.86	-1.24	-1.27	-0.50	NA	NA	NA	NA
Gross Product		38.43	41.82	38.59	33.46	33.20	32.50	26.98	26.43	22.62	22.49	20.55	22.04	16.11	22.43	20.32	18.35	15.37	16.34	14.35	12.48	9.92	8.53	6.13	2.29	NA	NA	NA	NA
Royalty Delivery Of Drug Supplies And Others		3.53	6.15	0.93	2.00	2.33	1.11	0.72	3.93	0.33	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Government Contract		NA	0.10	0.00	1.00	NA	2.00	2.50	NA	NA	1.00	1.00	5.50	3.00	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Product		26.00	29.54	27.13	23.88	23.75	22.78	19.19	18.55	16.20	17.57	16.01	17.05	12.38	17.75	16.29	14.97	12.68	13.83	11.72	10.17	8.05	7.29	4.87	1.79	NA	NA	NA	NA

Plots across concepts

Line plots across dimensions of each concept